img

Global Panuveitis Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Panuveitis Treatment Market Research Report 2024

Panuveitis is a serious inflammatory condition that affects the uveal tract of the eye, which includes the iris, ciliary body, and choroid. Treatment for panuveitis usually involves a combination of medications and sometimes surgery.
According to Mr Accuracy reports’s new survey, global Panuveitis Treatment market is projected to reach US$ 6485 million in 2029, increasing from US$ 3514 million in 2022, with the CAGR of 9.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Panuveitis Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Panuveitis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis AG
Bausch Health Inc.
AbbVie Inc.
Tarsier Pharma
EyeGate Pharmaceuticals, Inc.
Alimera Science Inc.
Eyepoint Pharmaceutical
Santen Pharmaceutical
Segment by Type
Oral
Topical

Segment by Application


Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Panuveitis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Panuveitis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Topical
1.3 Market by Application
1.3.1 Global Panuveitis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Panuveitis Treatment Market Perspective (2018-2029)
2.2 Panuveitis Treatment Growth Trends by Region
2.2.1 Global Panuveitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Panuveitis Treatment Historic Market Size by Region (2018-2024)
2.2.3 Panuveitis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Panuveitis Treatment Market Dynamics
2.3.1 Panuveitis Treatment Industry Trends
2.3.2 Panuveitis Treatment Market Drivers
2.3.3 Panuveitis Treatment Market Challenges
2.3.4 Panuveitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Panuveitis Treatment Players by Revenue
3.1.1 Global Top Panuveitis Treatment Players by Revenue (2018-2024)
3.1.2 Global Panuveitis Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Panuveitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Panuveitis Treatment Revenue
3.4 Global Panuveitis Treatment Market Concentration Ratio
3.4.1 Global Panuveitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Panuveitis Treatment Revenue in 2022
3.5 Panuveitis Treatment Key Players Head office and Area Served
3.6 Key Players Panuveitis Treatment Product Solution and Service
3.7 Date of Enter into Panuveitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Panuveitis Treatment Breakdown Data by Type
4.1 Global Panuveitis Treatment Historic Market Size by Type (2018-2024)
4.2 Global Panuveitis Treatment Forecasted Market Size by Type (2024-2029)
5 Panuveitis Treatment Breakdown Data by Application
5.1 Global Panuveitis Treatment Historic Market Size by Application (2018-2024)
5.2 Global Panuveitis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Panuveitis Treatment Market Size (2018-2029)
6.2 North America Panuveitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Panuveitis Treatment Market Size by Country (2018-2024)
6.4 North America Panuveitis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Panuveitis Treatment Market Size (2018-2029)
7.2 Europe Panuveitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Panuveitis Treatment Market Size by Country (2018-2024)
7.4 Europe Panuveitis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Panuveitis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Panuveitis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Panuveitis Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Panuveitis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Panuveitis Treatment Market Size (2018-2029)
9.2 Latin America Panuveitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Panuveitis Treatment Market Size by Country (2018-2024)
9.4 Latin America Panuveitis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Panuveitis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Panuveitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Panuveitis Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Panuveitis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Panuveitis Treatment Introduction
11.1.4 Novartis AG Revenue in Panuveitis Treatment Business (2018-2024)
11.1.5 Novartis AG Recent Development
11.2 Bausch Health Inc.
11.2.1 Bausch Health Inc. Company Detail
11.2.2 Bausch Health Inc. Business Overview
11.2.3 Bausch Health Inc. Panuveitis Treatment Introduction
11.2.4 Bausch Health Inc. Revenue in Panuveitis Treatment Business (2018-2024)
11.2.5 Bausch Health Inc. Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Detail
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Panuveitis Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Panuveitis Treatment Business (2018-2024)
11.3.5 AbbVie Inc. Recent Development
11.4 Tarsier Pharma
11.4.1 Tarsier Pharma Company Detail
11.4.2 Tarsier Pharma Business Overview
11.4.3 Tarsier Pharma Panuveitis Treatment Introduction
11.4.4 Tarsier Pharma Revenue in Panuveitis Treatment Business (2018-2024)
11.4.5 Tarsier Pharma Recent Development
11.5 EyeGate Pharmaceuticals, Inc.
11.5.1 EyeGate Pharmaceuticals, Inc. Company Detail
11.5.2 EyeGate Pharmaceuticals, Inc. Business Overview
11.5.3 EyeGate Pharmaceuticals, Inc. Panuveitis Treatment Introduction
11.5.4 EyeGate Pharmaceuticals, Inc. Revenue in Panuveitis Treatment Business (2018-2024)
11.5.5 EyeGate Pharmaceuticals, Inc. Recent Development
11.6 Alimera Science Inc.
11.6.1 Alimera Science Inc. Company Detail
11.6.2 Alimera Science Inc. Business Overview
11.6.3 Alimera Science Inc. Panuveitis Treatment Introduction
11.6.4 Alimera Science Inc. Revenue in Panuveitis Treatment Business (2018-2024)
11.6.5 Alimera Science Inc. Recent Development
11.7 Eyepoint Pharmaceutical
11.7.1 Eyepoint Pharmaceutical Company Detail
11.7.2 Eyepoint Pharmaceutical Business Overview
11.7.3 Eyepoint Pharmaceutical Panuveitis Treatment Introduction
11.7.4 Eyepoint Pharmaceutical Revenue in Panuveitis Treatment Business (2018-2024)
11.7.5 Eyepoint Pharmaceutical Recent Development
11.8 Santen Pharmaceutical
11.8.1 Santen Pharmaceutical Company Detail
11.8.2 Santen Pharmaceutical Business Overview
11.8.3 Santen Pharmaceutical Panuveitis Treatment Introduction
11.8.4 Santen Pharmaceutical Revenue in Panuveitis Treatment Business (2018-2024)
11.8.5 Santen Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Panuveitis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Global Panuveitis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Panuveitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Panuveitis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Panuveitis Treatment Market Share by Region (2018-2024)
Table 8. Global Panuveitis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Panuveitis Treatment Market Share by Region (2024-2029)
Table 10. Panuveitis Treatment Market Trends
Table 11. Panuveitis Treatment Market Drivers
Table 12. Panuveitis Treatment Market Challenges
Table 13. Panuveitis Treatment Market Restraints
Table 14. Global Panuveitis Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Panuveitis Treatment Market Share by Players (2018-2024)
Table 16. Global Top Panuveitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Panuveitis Treatment as of 2022)
Table 17. Ranking of Global Top Panuveitis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Panuveitis Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Panuveitis Treatment Product Solution and Service
Table 21. Date of Enter into Panuveitis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Panuveitis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Panuveitis Treatment Revenue Market Share by Type (2018-2024)
Table 25. Global Panuveitis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Panuveitis Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Panuveitis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Panuveitis Treatment Revenue Market Share by Application (2018-2024)
Table 29. Global Panuveitis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Panuveitis Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Panuveitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Panuveitis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Panuveitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Panuveitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Panuveitis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Panuveitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Panuveitis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Panuveitis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Panuveitis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Panuveitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Panuveitis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Panuveitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Panuveitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Panuveitis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Panuveitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis AG Company Detail
Table 47. Novartis AG Business Overview
Table 48. Novartis AG Panuveitis Treatment Product
Table 49. Novartis AG Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 50. Novartis AG Recent Development
Table 51. Bausch Health Inc. Company Detail
Table 52. Bausch Health Inc. Business Overview
Table 53. Bausch Health Inc. Panuveitis Treatment Product
Table 54. Bausch Health Inc. Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 55. Bausch Health Inc. Recent Development
Table 56. AbbVie Inc. Company Detail
Table 57. AbbVie Inc. Business Overview
Table 58. AbbVie Inc. Panuveitis Treatment Product
Table 59. AbbVie Inc. Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 60. AbbVie Inc. Recent Development
Table 61. Tarsier Pharma Company Detail
Table 62. Tarsier Pharma Business Overview
Table 63. Tarsier Pharma Panuveitis Treatment Product
Table 64. Tarsier Pharma Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 65. Tarsier Pharma Recent Development
Table 66. EyeGate Pharmaceuticals, Inc. Company Detail
Table 67. EyeGate Pharmaceuticals, Inc. Business Overview
Table 68. EyeGate Pharmaceuticals, Inc. Panuveitis Treatment Product
Table 69. EyeGate Pharmaceuticals, Inc. Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 70. EyeGate Pharmaceuticals, Inc. Recent Development
Table 71. Alimera Science Inc. Company Detail
Table 72. Alimera Science Inc. Business Overview
Table 73. Alimera Science Inc. Panuveitis Treatment Product
Table 74. Alimera Science Inc. Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 75. Alimera Science Inc. Recent Development
Table 76. Eyepoint Pharmaceutical Company Detail
Table 77. Eyepoint Pharmaceutical Business Overview
Table 78. Eyepoint Pharmaceutical Panuveitis Treatment Product
Table 79. Eyepoint Pharmaceutical Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 80. Eyepoint Pharmaceutical Recent Development
Table 81. Santen Pharmaceutical Company Detail
Table 82. Santen Pharmaceutical Business Overview
Table 83. Santen Pharmaceutical Panuveitis Treatment Product
Table 84. Santen Pharmaceutical Revenue in Panuveitis Treatment Business (2018-2024) & (US$ Million)
Table 85. Santen Pharmaceutical Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Panuveitis Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Panuveitis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Topical Features
Figure 5. Global Panuveitis Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Panuveitis Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies and Drug Stores Case Studies
Figure 10. Panuveitis Treatment Report Years Considered
Figure 11. Global Panuveitis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Panuveitis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Panuveitis Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Panuveitis Treatment Market Share by Players in 2022
Figure 15. Global Top Panuveitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Panuveitis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Panuveitis Treatment Revenue in 2022
Figure 17. North America Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Panuveitis Treatment Market Share by Country (2018-2029)
Figure 19. United States Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Panuveitis Treatment Market Share by Country (2018-2029)
Figure 23. Germany Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Panuveitis Treatment Market Share by Region (2018-2029)
Figure 31. China Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Panuveitis Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Panuveitis Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Panuveitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Novartis AG Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 46. Bausch Health Inc. Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 47. AbbVie Inc. Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 48. Tarsier Pharma Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 49. EyeGate Pharmaceuticals, Inc. Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 50. Alimera Science Inc. Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 51. Eyepoint Pharmaceutical Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 52. Santen Pharmaceutical Revenue Growth Rate in Panuveitis Treatment Business (2018-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed